Emerging Technologies
The company's Auto B-line Counter product uses AI to help providers assess abnormal lung conditions.
The medtech company will use the funds to speed up product innovation and expand its reach globally.
The three-year collaboration will focus on developing and implementing virtual reality tools for neurorehabilitation and chronic condition management.
Josh Sackman, president and cofounder of AppliedVR, discusses the new Healthcare Common Procedure Coding System (HCPSC) Level II code for the company's product RelieVRx.
During a series of talks at vMed 2023, speakers discussed the promise of XR use in mental healthcare and their cautious optimism around care delivery in the metaverse.
It has been approved for use in both clinical and home settings.
It seeks to support and accelerate the development of personalised healthcare and drug discovery.
Also, Jolly Good has collaborated with Brigham and Women's Hospital to create medical education VR content.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.